[HTML][HTML] The underestimated role of the p53 pathway in renal cancer
Simple Summary The TP53 tumor suppressor gene, the guardian of the genome, is mutated
or has an inactive pathway in most chemo-resistant tumors. Most studies focus on the role of …
or has an inactive pathway in most chemo-resistant tumors. Most studies focus on the role of …
[PDF][PDF] The Underestimated Role of the p53 Pathway in Renal Cancer. Cancers 2022, 14, 5733
A Amendolare, F Marzano, V Petruzzella, RA Vacca… - 2022 - pdfs.semanticscholar.org
The TP53 tumor suppressor gene is known as the guardian of the genome, playing a pivotal
role in controlling genome integrity, and its functions are lost in more than 50% of human …
role in controlling genome integrity, and its functions are lost in more than 50% of human …
[HTML][HTML] The Underestimated Role of the p53 Pathway in Renal Cancer
A Amendolare, F Marzano, V Petruzzella, RA Vacca… - Cancers, 2022 - ncbi.nlm.nih.gov
The TP53 tumor suppressor gene is known as the guardian of the genome, playing a pivotal
role in controlling genome integrity, and its functions are lost in more than 50% of human …
role in controlling genome integrity, and its functions are lost in more than 50% of human …
The Underestimated Role of the p53 Pathway in Renal Cancer.
A Amendolare, F Marzano, V Petruzzella, RA Vacca… - Cancers, 2022 - go.gale.com
The TP53 tumor suppressor gene, the guardian of the genome, is mutated or has an inactive
pathway in most chemo-resistant tumors. Most studies focus on the role of mutated TP53 in …
pathway in most chemo-resistant tumors. Most studies focus on the role of mutated TP53 in …
The Underestimated Role of the p53 Pathway in Renal Cancer
A Amendolare, F Marzano, V Petruzzella, RA Vacca… - CANCERS, 2022 - air.unimi.it
Abstract Simple Summary The TP53 tumor suppressor gene, the guardian of the genome, is
mutated or has an inactive pathway in most chemo-resistant tumors. Most studies focus on …
mutated or has an inactive pathway in most chemo-resistant tumors. Most studies focus on …
The Underestimated Role of the p53 Pathway in Renal Cancer
A Amendolare, F Marzano, V Petruzzella, RA Vacca… - CANCERS, 2022 - ricerca.uniba.it
The TP53 tumor suppressor gene is known as the guardian of the genome, playing a pivotal
role in controlling genome integrity, and its functions are lost in more than 50% of human …
role in controlling genome integrity, and its functions are lost in more than 50% of human …
The Underestimated Role of the p53 Pathway in Renal Cancer
A Amendolare, F Marzano, V Petruzzella, RA Vacca… - …, 2022 - search.proquest.com
The TP53 tumor suppressor gene is known as the guardian of the genome, playing a pivotal
role in controlling genome integrity, and its functions are lost in more than 50% of human …
role in controlling genome integrity, and its functions are lost in more than 50% of human …
[PDF][PDF] The Underestimated Role of the p53 Pathway in Renal Cancer. Cancers 2022, 14, 5733
A Amendolare, F Marzano, V Petruzzella, RA Vacca… - 2022 - academia.edu
The TP53 tumor suppressor gene is known as the guardian of the genome, playing a pivotal
role in controlling genome integrity, and its functions are lost in more than 50% of human …
role in controlling genome integrity, and its functions are lost in more than 50% of human …
The Underestimated Role of the p53 Pathway in Renal Cancer
A Amendolare, F Marzano, V Petruzzella, R Vacca… - Cancers, 2022 - europepmc.org
The TP53 tumor suppressor gene is known as the guardian of the genome, playing a pivotal
role in controlling genome integrity, and its functions are lost in more than 50% of human …
role in controlling genome integrity, and its functions are lost in more than 50% of human …
The Underestimated Role of the p53 Pathway in Renal Cancer.
A Amendolare, F Marzano, V Petruzzella… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: The TP53 tumor suppressor gene, the guardian of the genome, is
mutated or has an inactive pathway in most chemo-resistant tumors. Most studies focus on …
mutated or has an inactive pathway in most chemo-resistant tumors. Most studies focus on …